ConductScience.org, home

Paper40568599

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed.

Li-Fei M and 5 others. Front Immunol, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed. Papers, record 40568599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40568599

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed.
PubMed
Journal
Front Immunol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.45, provisional
iCite
Revised in PubMed
2025-06-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li-Fei MMeng
2Ren SMSi-Meng
3Wang JJun
4Zhao WJWei-Jun
5Chen JJian
6Hu WTWen-Tao

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Adenocarcinoma of LungMajor topic
Lung NeoplasmsMajor topic
B7-H1 AntigenMajor topic
Biomarkers, TumorMajor topic
Humans
Prognosis
Gene Expression Regulation, Neoplastic
Gene Expression Profiling
Male
Female
Databases, Genetic

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136934264Exosomal MFI2-AS1 sponge miR-107 promotes non-small cell lung cancer progression through NFAT5.Cancer Cell Int2023https://conductscience.org/library/papers/36934264PubMed
238333021SPRR1B is Related to the Immune Microenvironment and Can Be Used as a Biomarker for the Diagnosis of Psoriasis.Int J Gen Med2024https://conductscience.org/library/papers/38333021PubMed
332919526
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Lancet Oncol2020https://conductscience.org/library/papers/32919526PubMed
432001626Neoadjuvant checkpoint blockade for cancer immunotherapy.Science2020https://conductscience.org/library/papers/32001626PubMed
533501784Identification of small proline-rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis.Thorac Cancer2021https://conductscience.org/library/papers/33501784PubMed
630654138An extensive experimental survey of regression methods.Neural Netw2019https://conductscience.org/library/papers/30654138PubMed
731623662Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.J Immunother Cancer2019https://conductscience.org/library/papers/31623662PubMed
830171052Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade.Cancer Res2018https://conductscience.org/library/papers/30171052PubMed
939892819Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity.J Hepatol2025https://conductscience.org/library/papers/39892819PubMed
1028039262Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma.Clin Cancer Res2017https://conductscience.org/library/papers/28039262PubMed
1138909843Melanotransferrin (MELTF, MFI2, CD228) Expression Attenuates Malignant Melanoma Progression in the A375-Luc2 Murine Metastasis Model and Human Patients.J Invest Dermatol2024https://conductscience.org/library/papers/38909843PubMed
1236800443SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models.Mol Cancer Ther2023https://conductscience.org/library/papers/36800443PubMed
1321190562PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.Mol Cancer2010https://conductscience.org/library/papers/21190562PubMed
1437814076Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma.Cell Oncol (Dordr)2024https://conductscience.org/library/papers/37814076PubMed
1534112123GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.BMC Pulm Med2021https://conductscience.org/library/papers/34112123PubMed
1639901895CD25 downregulation by tumor exosomal microRNA-15a promotes interleukin-17-producing γδ-T-cells-mediated radioresistance in nasopharyngeal carcinoma.MedComm (2020)2025https://conductscience.org/library/papers/39901895PubMed
1738410229Sinensetin suppresses breast cancer cell progression via Wnt/β-catenin pathway inhibition.Transl Cancer Res2024https://conductscience.org/library/papers/38410229PubMed
1840081220Resistance to immunotherapy in non-small cell lung cancer: Unraveling causes, developing effective strategies, and exploring potential breakthroughs.Drug Resist Updat2025https://conductscience.org/library/papers/40081220PubMed
1933127882The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer.Cell Death Dis2020https://conductscience.org/library/papers/33127882PubMed
2029749538TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.Oncol Rep2018https://conductscience.org/library/papers/29749538PubMed

See all 67 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42614290New insights into lysosomal ferroptosis-related prognostic signatures in prostate cancer: evidence from bulk and single-cell transcriptomic analysis.Front Cell Dev Biol2026https://conductscience.org/library/papers/42614290PubMed
42544237PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated Analysis.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42544237PubMed
42401850Machine learning-driven development of a novel unfolded protein response-related gene signature for predicting lung adenocarcinoma patient prognosis.BMC Cancer2026https://conductscience.org/library/papers/42401850PubMed
42196541Integrative Bulk and Single-Cell Transcriptomic Analysis Identifies a Hypoxia- and Lipid Metabolism-Related Prognostic Signature in Oral Squamous Cell Carcinoma: A Retrospective Study.Int J Mol Sci2026https://conductscience.org/library/papers/42196541PubMed
42180240Association between duration of dysphagia and dysphonia with insomnia: results from the National Health Interview Survey.Front Neurol2026https://conductscience.org/library/papers/42180240PubMed
41968824AR and ITGAL: Key Mediators of Andrographis paniculata's Anti-Psoriatic Effects Revealed by Multi-Omics Analysis.Comb Chem High Throughput Screen2026https://conductscience.org/library/papers/41968824PubMed
41899571An Analysis of G3BP2 in Non-Small Cell Lung Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/41899571PubMed
41634312Integrative analysis of transcriptome and single-cell sequencing combined with experimental validation identifies biomarkers associated with T cell and senescence in sepsis.Sci Rep2026https://conductscience.org/library/papers/41634312PubMed
40787424Development and validation of transient receptor potential channel-related signature for predicting prognosis in patients with lung adenocarcinoma.Oncol Lett2025https://conductscience.org/library/papers/40787424PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADGRF4221393PubTator's text mininghttps://conductscience.org/library/genes/221393NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
GREB1L80000PubTator's text mininghttps://conductscience.org/library/genes/80000NCBI Gene
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
LIPK643414PubTator's text mininghttps://conductscience.org/library/genes/643414NCBI Gene
SPRR1B6699PubTator's text mininghttps://conductscience.org/library/genes/6699NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40568599

GET https://conductscience.org/api/papers/v1/40568599/references?page=2